Skip to main content
OpenTrials

Clinical trial condition

Nucleophosmin 1-mutated Acute Myeloid Leukemia

Explore clinical trials studying Nucleophosmin 1-mutated Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Nucleophosmin 1-mutated Acute Myeloid Leukemia trial results

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

NCT05735184

Conditions
AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, +19 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Bowyer Oncology Center Los Angeles, California, United States
View all 44 locations
View Trial Details

Related conditions